Deerfield Management

Thrilled to team up with Nikhil Krishnan and Out-Of-Pocket for this hackathon! We're focusing on some of healthcare's toughest challenges—because solving important problems should be rewarding and fun. If you're passionate about crafting elegant solutions to tricky technical puzzles alongside smart, dedicated folks, join us for a weekend packed with creativity, collaboration, (maybe) cursor, and (probably) caffeine. See you there!

What sparks the transformation of compelling academic ideas into potentially life-changing therapies?   At Deerfield, we believe it’s the power of collaboration. Our new animation brings to life the way our firm joins forces with leading academic institutions, aiming to speed discoveries along the path from the research laboratory to a real person’s medicine cabinet.   By offering hands-on partnership via our Deerfield Discovery and Development team (3DC), we’re eager to empower promising scientists. Watch the video to find out how!   Want to dive deeper? Click the link in the comments to learn more about how Deerfield collaborates with research institutions around the country (and the world!).

We are excited to partner with Nikhil at Out-Of-Pocket for a B2B healthcare AI hackathon this October!   Here’s what you can look forward to: ✅ Teaming up with real healthcare companies 🤖 Getting hands-on with the latest AI tools 🚀 Showcasing your ideas at a public demo day at Cure. 🤝 Connecting with potential future partners and customers   If you’re passionate about healthcare and AI, don’t miss this chance to build, connect, and showcase your ideas. See below to learn how to apply!

Deerfield Partner Karen Heidelberger recently joined leaders from academia, industry, and government at #UIDPEurope to discuss how university-industry partnerships continue to evolve.    Karen shared: “Conversations like these reinforce how collaboration between academia and industry is essential for not only translating research ideas into real-world products but preparing a well-trained scientific workforce. It's energizing to hear diverse perspectives on how we can bridge existing gaps and make a meaningful impact.”

How does Deerfield work with Columbia University? Over breakfast, of course! Nadim Shohdy, Ph.D., William Slattery, and other members of our Deerfield Discovery and Development (3DC) team joined our partners at Columbia for an info session and networking breakfast highlighting our research collaboration, Hudson Heights Innovations. As Director of Innovation Alliances Sam Galindo (a Columbia alum herself) said, “It’s always great to reconnect with familiar faces and meet new collaborators who share our passion for advancing science.” Hudson Heights Innovation is dedicated to advancing translational research out of Columbia labs and into clinical development. Our team shared great conversations with Columbia faculty and Columbia Technology Ventures about therapeutic development priorities and opportunities for collaboration. To learn more about Hudson Heights Innovations, check out the link in comments.

The Deerfield Management team rolled up our sleeves once again to prepare 100+ sandwiches in support of Crossroads Community Services NYC, an organization steadfast in its mission to fight hunger and homelessness in New York City since 1990. We were honored to be joined by Crossroads’ Executive Director, Patrick Bergquist, MPA, who shared how these sandwiches will make a meaningful difference in the lives of individuals and families right in our own neighborhood. Hearing firsthand about the challenges faced by so many New Yorkers reminds us all of the importance of giving back and supporting local initiatives that make our city stronger.

Dana-Farber Cancer Institute luminaries joined Deerfielders at Cure. for an inspiring, intimate conversation that energized our team and the broader community of Dana-Farber supporters. We are grateful to our esteemed panel: Moira Forbes, EVP at Forbes and Dana-Farber Trustee; Benjamin L. Ebert, MD, PhD, President and CEO of Dana-Farber Cancer Institute and Richard and Susan Smith Professor of Medicine at Harvard Medical School; and William G. Kaelin Jr., MD, 2019 Nobel Laureate Dana-Farber Cancer Institute and Sidney Farber Professor of Medicine at Harvard Medical School. Their thoughtful perspectives and unwavering commitment to advancing cancer research left a powerful impression. #CancerResearch #AdvancingHealthcare

Congratulations to Deerfield portfolio company Actio Biosciences, Inc. on raising a $66 million Series B! We are proud to support the Actio team as they advance their mission to develop new therapeutics that target shared underlying biology in both rare and common diseases.

How are healthcare leaders navigating 2025’s rapidly evolving policy and innovation landscape? Deerfield’s Scott Donohue, Senior Director of Market Access, joined 100+ CEOs and industry leaders in contributing to Cure.'s The Future of Healthcare Innovation 2025 report, offering his candid perspective on policy, funding, and the road ahead. This report captures a distinct moment: uncertainty remains, but leaders share a sense of cautious optimism. 🔗 For a deeper look at the findings, including must-read strategies for healthcare innovators, check out the full report: https://lnkd.in/gGQKWVVT *Cure is an affiliate of Deerfield.

We’re excited to congratulate Deerfield partner Howie Furst and Deerfield principal Mike Hurley, MD, MS on their appointments to Advancium Health Network’s Board of Directors!   Advancium Health Network is a public charity launched by Deerfield Management and the Deerfield Foundation that combines for-profit infrastructure with non-profit ideals to confront healthcare’s most daunting gaps in early-stage innovation for underserved patients.